Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[UTHR] United Therapeutics Corp - Pretax Margin
Data updated 2024-Mar-17 (Sunday)Note: Detailed Statistics for Pretax Margin in Income Statement for United Therapeutics Corp [NASDAQ:UTHR] with frequency distribution chart that analyze trends & history . Pretax Margin is a profitability metric calculated as EBT / Revenue. View Income Statement for broader context
Share
Quarterly Pretax Margin values for United Therapeutics Corp are rounded to enhance readability
| 2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
|---|---|---|---|---|---|---|
| Pretax Margin | 48.1% | 57.7% | 56.2% | 57.6% | 36.4% | 60.6% |
| Sequential Quarter Growth | -16.8% | +2.7% | -2.4% | +58.3% | -39.9% | +87.7% |
| Quarter-on Quarter Growth | +32.1% | -4.7% | +74.2% | -13.8% | +7.5% | +31.8% |
Annual Pretax Margin values for United Therapeutics Corp are rounded to enhance readability
| 2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
|---|---|---|---|---|---|---|
| Pretax Margin | 54.8% | 49.1% | 35.2% | 43.1% | -11.4% | 46.6% |
| Year-on-Year Growth | +11.5% | +39.4% | -18.2% | +478.3% | -124.4% | +4.4% |
| 2-yr CAGR | +24.7% | +6.8% | -3.9% | -16.1% | ||
| 3-yr CAGR | +8.3% | -8.9% | -1.2% | -13.2% | ||
| 4-yr CAGR | +1.3% | -5.7% | -10.2% | +3.4% | ||
| 5-yr CAGR | +3.3% | +1.9% | -11.9% | -9.6% | +13.3% |
Frequency distribution of quarterly Pretax Margin values from 2010-Jun-30 grouped into buckets. Latest Pretax Margin value is 48.1 as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for United Therapeutics Corp mapped with quarterly Pretax Margin values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Pretax Margin above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for United Therapeutics Corp with subsequent post-earnings performance given Pretax Margin values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
| Underperform (relative perf.) | Outperform (relative perf.) | |
|---|---|---|
| Pretax Margin - Low | 67% | 33% |
| Pretax Margin - Medium | 44% | 56% |
| Pretax Margin - High | 39% | 61% |
| Pretax Margin (Sequential growth %) - Low | 61% | 39% |
| Pretax Margin (Sequential growth %) - Medium | 44% | 56% |
| Pretax Margin (Sequential growth %) - High | 41% | 59% |
| Pretax Margin (QoQ growth %) - Low | 53% | 47% |
| Pretax Margin (QoQ growth %) - Medium | 53% | 47% |
| Pretax Margin (QoQ growth %) - High | 38% | 63% |
Related to United Therapeutics Corp
Information for United Therapeutics Corp
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2024-Nov-22 on Google
SEC Reports : Quarterly reports around 2024-Nov-22 on SEC Edgar
Compare United Therapeutics Corp with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes United Therapeutics Corp
Industry : Biotechnology industry performance which includes United Therapeutics Corp